Human Drugs

× UPDATE! Updated as of 16 October 2024.
 
Product Information
Registration Number
Generic Name
Brand Name
Dosage Strength
Dosage Form
Pharmacologic Category
Manufacturer
Country of Origin
Application Type
Issuance Date
Expiry Date
View DRP-15042 Irbesartan + Amlodipine (as Besilate) Adisart 300 mg/5mg Film-Coated Tablet Angiotensin II Receptor Blocker (ARB)/Calcium Channel Blocker Magbro Healthcare Pvt. Ltd. India Initial 27 March 2024 27 March 2029
View DRP-15038 Losartan Potassium + Amlodipine (as besilate) Cardivest Plus 50 mg/5 mg Film-Coated Tablet Angiotensin II receptor blocker (ARB) and calcium channel blocker Magbro Healthcare Pvt. Ltd. Philippines Initial 26 March 2024 26 March 2029
View DR-XY49027 Febuxostat Febulas 40 40 mg Film-Coated Tablet Anti-gout (Preparation Inhibiting Uric Acid Production) Delta Pharma Ltd. Bangladesh Initial 26 March 2024 26 March 2029
View HRP-644 Oral Rehydration Salts SRA-ORS Lychee FORMULATION Each sachet (4.1 g) contains: Glucose Anhydrous 2.70 g Trisodium Citrate Dihydrate 580 mg Sodium Chloride 520 mg Potassium Chloride 300 mg Granules for Oral Solution (Lychee Flavor) Electrolytes with Carbohydrates Azarias Pharmaceutical Laboratories, Inc. Philippines Initial 26 March 2024 26 March 2029
View HRP-645 Oral Rehydration Salts SRA-ORS Melon FORMULATION Each sachet (4.1 g) contains: Glucose Anhydrous 2.70 g Trisodium Citrate Dihydrate 580 mg Sodium Chloride 520 mg Potassium Chloride 300 mg Granules for Oral Solution (Melon Flavor) Electrolytes with Carbohydrates Azarias Pharmaceutical Laboratories, Inc. Philippines Initial 26 March 2024 26 March 2029
View HRP-646 Oral Rehydration Salts SRA-ORS Strawberry FORMULATION Each sachet (4.1 g) contains: Glucose Anhydrous 2.70 g Trisodium Citrate Dihydrate 580 mg Sodium Chloride 520 mg Potassium Chloride 300 mg Granules for Oral Solution (Strawberry Flavor) Electrolytes with Carbohydrates Azarias Pharmaceutical Laboratories, Inc. Philippines Initial 26 March 2024 26 March 2029
View DR-XY49028 Rivaroxaban Verxaban 20 mg Film-Coated Tablet Antithrombotic Agent (Direct factor Xa inhibitor) Lloyd Laboratories, Inc. Philippines Initial 26 March 2024 26 March 2029
View DRP-15044 Rosuvastatin (as calcium) Lipidbloc 10 mg Film-Coated Tablet Lipid Modifying Agent (HMG CoA Reductase Inhibitor) Healer's Lab (Unit II) India Initial 26 March 2024 26 March 2029
View DR-XY49017 Febuxostat Febulas 80 80 mg Film-Coated Tablet Anti-gout (Preparation Inhibiting Uric Acid Production) Delta Pharma Ltd. Bangladesh Initial 26 March 2024 26 March 2029
View DRP-5948-02 Piperacillin (as sodium) + Tazobactam (as sodium) Tazomin 4 g/500 mg Powder for Injection (IM/IV) Antibacterial Inject Care Parenterals Pvt. Ltd. India Automatic Renewal (Correction) 29 May 2024 21 January 2025
View DR-XY49030 Norepinephrine (as bitartrate monohydrate) Nefrinor 1 mg/mL (4 mg/4 mL) Solution for Infusion (I.V.) Adrenergic/Dopaminergic Agent. Mefar İlaç Sanayii A.Ş. Turkey Initial 27 March 2024 27 March 2029
View DRP-15045 Fosfomycin (as trometamol) Exelfos 3g Granules For Oral Solution Antibacterial Labiana Pharmaceuticals, SLU Spain Initial 27 March 2024 27 March 2029
View DR-XY49025 Sterile Water for Injection. none None Sterile Water for Injection Parenteral Diluent Zhejiang Ruixin Pharmaceutical Co. Ltd. China Initial 27 March 2024 27 March 2029
View DR-XY49026 Ascorbic Acid Asco-C 250 mg/mL (500 mg/ 2 mL) Solution for Injection Vitamin Tianjin Kingyork Group Hubei Tianyao Pharmaceutical Co., Ltd. China Initial 27 March 2024 27 March 2029
View DRP-12424-03 Omeprazole (as sodium monohydrate) Omepace 40 mg Lyophilized Powder for Injection (I.V.) Proton Pump Inhibitor Reyoung Pharmaceutical Co., Ltd. China CLIDP Conversion 17 March 2024 04 August 2027
View DRP-12424-04 Omeprazole (as sodium monohydrate) Briandazole 40 mg Lyophilized Powder for Injection (I.V.) Proton Pump Inhibitor Reyoung Pharmaceutical Co., Ltd China CLIDP Conversion 28 March 2024 04 August 2027
View DRP-1272-13 Hydrocortisone (as sodium succinate) Aecor-100 100 mg Powder for Injection (IM/IV) Corticosteroid Umedica Laboratories Pvt. Ltd. India CLIDP Conversion 10 March 2024 07 October 2028
View DRP-12788-03 Omeprazole None 40 mg Delayed-Release Capsule Proton Pump Inhibitor Sapphire Lifesciences Pvt. Ltd India CLIDP Conversion 26 March 2024 07 October 2027
View DRP-12864-02 Glimepiride Glimegen 2 mg Tablet Oral Hypoglycemic Agent Ratnatris Pharmaceuticals Pvt. Ltd India CLIDP Conversion 10 March 2024 18 October 2027
View DRP-12864-03 Glimepiride Retaglim 2 mg Tablet Oral Hypoglycemic Agent Ratnatris Pharmaceuticals Private Limited India CLIDP Conversion 29 March 2024 18 October 2027